Photo taken from Chadi Hage Chehade/X
Sep 29, 2024, 01:39
Chadi Hage Chehade: Post Hoc analysis of ph3 VISION trial prostate cancer
Chadi Hage Chehade, Post-Doctoral Research Fellow at Huntsman Cancer Institute, shared on X:
“Just out in European Urology.
Check out our editorial highlighting a post hoc analysis of ph3 VISION trial prostate cancer.
In patients receiving Lu-177, extent of PSA response correlated with survival outcomes and PROs.”
Source: Chadi Hage Chehade/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 20, 2025, 20:33
Jan 20, 2025, 20:31
Jan 20, 2025, 20:26
Jan 20, 2025, 20:21
Jan 20, 2025, 20:12
Jan 20, 2025, 20:10
Jan 20, 2025, 20:08
Jan 20, 2025, 20:06
Jan 20, 2025, 20:03